Cellectar Biosciences, Inc. Gains 28.71%

Wed, Dec 02, 2020 at 05:32 PM
Cellectar Biosciences, Inc. Gains 28.71%

Cellectar Biosciences, Inc. (CLRB:NASDAQ) soared at $1.95, representing a gain of 28.7%. On Tue 01 Dec 20, CLRB:NASDAQ hit a New 2-Week High of $1.52. The stock appeared on our News Catalysts scanner on Fri 27 Nov 20 at 07:25 PM in the 'ACQUISITION' category. From Tue 17 Nov 20, the stock recorded 77.78% Up Days and 70.00% Green Days

About Cellectar Biosciences, Inc. (CLRB:NASDAQ)

Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.